Regulations/FDA QMSR/Updates & Assets
Updates & Assets · FDA QMSR

Updates & Assets for FDA QMSR.

This page is the living shelf for validated assets, weekly signals, revision notes, and future public tools. Nothing here should look published-ready until the source trail and boundary have been checked.

Source basis: Quality Management System Regulation amendments to 21 CFR Part 820Use: evidence-readinessBoundary: not legal advice
FDA QMSR TRACE 21 CFR PART 820 SCQMSR FINAL RULE ISO 13485:2016 IFDA-SPECIFIC PRO
/ Asset shelf

Public assets attach only after source validation.

FDA QMSR
Asset 01

QMSR transition tracker

Future asset for FDA QMSR; publish only after source check, date check, boundary review, and revision note.

Asset 02

Part 820/ISO 13485 bridge checklist

Future asset for FDA QMSR; publish only after source check, date check, boundary review, and revision note.

Asset 03

supplier control evidence map

Future asset for FDA QMSR; publish only after source check, date check, boundary review, and revision note.

Asset 04

inspection pull-list

Future asset for FDA QMSR; publish only after source check, date check, boundary review, and revision note.

Asset 05

training effectiveness worksheet

Future asset for FDA QMSR; publish only after source check, date check, boundary review, and revision note.

/ Watchlist

Updates must show what changed.

revision protocol
Protocol 01

Source revision

Record date, source URL, affected pages, and what interpretation changed.

Protocol 02

Weekly signal

Only promote signals that alter operating decisions, evidence expectations, market movement, or governance work.

Protocol 03

Checklist release

Each checklist needs version, source links, evidence fields, public-safe disclaimer, and review boundary.

Protocol 04

Retirement

Outdated pages should be marked, archived, or redirected without deleting the trace.